Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
762.710.04%
QQQ
715.570.1%
BTC/USD
77971.880.6134%
DIA
524.660.11%
GLD
403.600.06%
TLT
81.710.02%

Oramed Pharmaceuticals Inc (ORMP) Stock Price, Quote, News & History

ORMPNASDAQ
Trade with Public
Trade with Public
$4.78
-0.20-4.02%
At close: Sep 9, 5:00 PM EST
$4.90
0.122.51%
After Hours: 6:18 PM EST
OverviewNewsEarnings ForecastPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Oramed Pharmaceuticals (ORMP) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$4.94
Close
$4.78
Volume / Avg.
245.68K / 298.71K
Day Range
$4.70 - $4.94
52 Wk Range
2.09 - 5.47
Market Cap
$203.83M
P/E Ratio
1.21
Dividend Yield
5.02%
Exchange
NASDAQ
RSI
55
Short Interest
2.91%
Days to Cover
5.85

Recent Oramed Pharmaceuticals Inc News

Top 4 Health Care Stocks That May Crash This Quarter

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Avi Kapoor

Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.
Lisa Levin

Dow Tumbles 250 Points; CarMax Posts Upbeat Results

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday. Following the market opening Friday, the Dow traded down 0.74% to 33,695.28 while the NASDAQ fell 0.98% to 13,497.22. The S&P 500, also fell, dropping, 0.78% to 4,347.58.
Lisa Levin

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.
Lisa Levin

Why Oramed Pharmaceuticals Shares Are Trading Higher Today

Oramed Pharmaceuticals Inc (NASDAQ: ORMP) shares are trading higher after its partner completed Phase 3 trials of oral insulin in type 2 diabetes in China 
Vandana Singh

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-5.21M
Investing Cash Flow (TTM)
21.50M
Financing Cash Flow (TTM)
-16.68M
Free Cash Flow (TTM)
-7.14M
Capital Expenditure (TTM)
-1.93M
Net Change in Cash (TTM)
-387.00K

Valuation Metrics

Enterprise Value
$157.28M
PE Ratio (TTM)
1.21
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.65
Earnings Yield % (TTM)
82.93%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
2.07
Price / EBITDA (TTM)
2.76
Price / Free Cash Flow (TTM)
-
Book Value / Share
$7.63

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$15.25M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$4.94
Close
$4.78
Volume / Avg.
245.68K / 298.71K
Day Range
$4.70 - $4.94
52 Wk Range
2.09 - 5.47
Market Cap
$203.83M
P/E Ratio
1.21
Dividend Yield
5.02%
Exchange
NASDAQ
RSI
55
Short Interest
2.91%
Days to Cover
5.85

About

Sector
Health Care
Industry
Pharmaceuticals
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Oramed Pharmaceuticals (ORMP) stock?

A

You can purchase shares of Oramed Pharmaceuticals (NASDAQ:ORMP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Oramed Pharmaceuticals (ORMP) competitors?

Q

What is the forecast, or price target, for Oramed Pharmaceuticals (ORMP) stock?

A

There is no analysis for Oramed Pharmaceuticals to provide a consensus price target.

Q

What is the current price for Oramed Pharmaceuticals (ORMP)?

A

The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $4.9 last updated September 9, 2026 at 6:18 PM EDT.

Q

Does Oramed Pharmaceuticals (ORMP) pay a dividend?

A

There are no upcoming dividends for Oramed Pharmaceuticals.

Q

When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?

A

Oramed Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Oramed Pharmaceuticals (ORMP) going to split?

A

There is no upcoming split for Oramed Pharmaceuticals.

Q

What sector and industry does Oramed Pharmaceuticals (ORMP) operate in?

A

Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved